Tarsus Buys Investigational Ocular Antiseptic

Eyetube

Tarsus acquires the maker of an investigational ocular antiseptic; Alcon and RxSight partner to jointly develop adjustable PCIOLs; and the FDA will hold a meeting to discuss Sydnexis’ investigational low-dose atropine therapy for myopia. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Buzz on Eyetube

Glaucoma Today

MANAGEMENT OF MILD GLAUCOMA WITH SLT John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO PLACENTAL TISSUE TO SCAFFOLD THE CONJUNCTIVA I. Paul Singh, MD MANAGING FOCAL RESISTANCE DURING CANALOPLASTY USING GREEN ILUMIN TIP FEEDBACK Mahmoud A. Khaimi, MD THE IMPORTANCE (AND UNIMPORTANCE) OF ECL IN IG Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Manjool Shah, MD

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

Conjunctivochalasis and Hyaluronic Acid in the Dry Eye Space

Eyetube

Co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO, sit down with Damon Dierker, OD, FAAO, on To the Point to talk about his approach to conjunctivochalasis. Dr. Dierker notes that he prefers to start the dry eye management process by addressing more common patient symptoms, such as inflammation. If symptoms persist, it’s time to introduce conjunctivochalasis as a diagnosis into the conversation. Dr. Dierker covers what to look for and different treatment options, including a more significant intervention that he has found success with: plasma-based conjunctivoplasty. Drs. Garlich and Quint then pick Dr. Dierker’s brain on hyaluronic acid, how he’s integrated it into his clinic, and patient candidacy.

The Road Ahead in Glaucoma Treatment

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Jason Bacharach, MD

Eyetube

Jason Bacharach, MD, joins Arsham Sheybani, MD, and Iqbal Ike K. Ahmed, MD, FRCSC, to review the road ahead in glaucoma therapy, exploring treatments in the pipeline, industry investment, and more. He reviews new innovations in drug delivery and offers comments on some of the financial challenges experienced by practice owners. He says that by embracing new technology, physicians can encourage industry to invest in more innovative treatments.

EyewireTV

07.29.2026

07.29.2026

Outlook Therapeutics CEO Discusses FDA Approval of Lytenava for Wet AMD

Roche Receives Positive Opinion from EMA Committee for Wet AMD Treatment Susvimo

Glaukos Completes Enrollment in Pivotal Trial Evaluating Preserflo MicroShunt for POAG

Eyewire News

UK College of Optometrists Seeks Feedback on Major Update to Professional Practice Guidance

Annexon Secures Up to $200 Million Credit Facility to Support Global Commercialization Plans

EyePoint Completes Enrollment in Phase 3 Duravyu Trials for DME Ahead of Schedule

Stocks

Cataract

Exploring Nd:YAG Vitreolysis After Cataract Surgery for Symptomatic Eyes

PRIMA Retinal Implant Launched in EU

Visualizing the Angle

Integrating MIGS Without Disrupting Efficiency

Elara 900: Reinventing the Clinical Workhorse

Tarsus Buys Investigational Ocular Antiseptic

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Pediatric Cataract Surgery May Alter Coordination of Ocular Growth, International Study Finds

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

Refractive

Tarsus Buys Investigational Ocular Antiseptic

MIGS and Cataract Surgery

PRIMA Retinal Implant Launched in EU

It Is Not Good to Be Shallow

Refractive Considerations in a Glaucomatous Eye

Visualizing the Angle

07.23.2026

iVeena Reports FDA Alignment on Phase 2 Development Plan for Pediatric Myopia Candidate IVMED-85

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Moorfields and University College London Launch CADMUS Anterior Segment Imaging Dataset

07.17.2026

iVeena Reports Favorable Phase 1 Safety Data for Investigational Pediatric Myopia Therapy IVMED-85

Stay Updated

Follow Eyewire News

Retina

Iatrogenic Breaks During Macular Hole Surgery

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

PRIMA Retinal Implant Launched in EU

New Retina Radio Journal Club w/ VBS: Clinical Features and Outcomes of IOFB Removal

Dense Cataract

GA in Practice

07.31.2026

Annexon Secures Up to $200 Million Credit Facility to Support Global Commercialization Plans

07.31.2026

EyePoint Completes Enrollment in Phase 3 Duravyu Trials for DME Ahead of Schedule

07.30.2026

Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision-Related Behaviors in Retinal Degeneration Models

07.28.2026

CHMP Backs Roche’s Susvimo for Wet AMD, European Commission Decision Pending

Glaucoma

The Buzz on Eyetube

PRIMA Retinal Implant Launched in EU

Five MIGS Tips

Seen & Heard

iTrack Advance: Collector Channel Intubation

GATT in a Patient With Steroid-Response Glaucoma and Ocular Surface Medicamentosa

07.27.2026

Glaukos Completes Enrollment in US Pivotal Study of Preserflo MicroShunt for POAG

07.24.2026

Théa, Unither Pharmaceuticals Partner on Dedicated Ophthalmic Manufacturing Facility in France

07.21.2026

Fundamental XR, Orbis Report Early Success of VR Ophthalmic Training Program Across Africa

07.17.2026

Glaucoma UK Launches Nationwide Patient Survey Targeting 10,000 Responses

Featured Podcasts

Ophthalmology off the Grid

New Retina Radio

Eyewire News: The Podcast

Optometry

Conjunctivochalasis and Hyaluronic Acid in the Dry Eye Space

Ocular Updates Plans for Axpaxli NDA for Wet AMD